Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms.
Zermati Y, De Sepulveda P, Féger F, Létard S, Kersual J, Castéran N, Gorochov G, Dy M, Ribadeau Dumas A, Dorgham K, Parizot C, Bieche Y, Vidaud M, Lortholary O, Arock M, Hermine O, Dubreuil P.
Zermati Y, et al. Among authors: parizot c.
Oncogene. 2003 Feb 6;22(5):660-4. doi: 10.1038/sj.onc.1206120.
Oncogene. 2003.
PMID: 12569358